1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Spine Surgery Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Spine Surgery Products Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Spine Surgery Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Fusion Products
6.3.1.1. Cervical Fusion
6.3.1.2. Interbody Fusion
6.3.1.3. Spinal Fixation
6.3.1.4. Minimally Invasive Surgical (MIS) Devices
6.3.1.5. Spine Biologics
6.3.1.5.1. Demineralized Bone Matrix
6.3.1.5.2. Synthetic Bone Graft Substitutes
6.3.2. Non-fusion Products
6.3.2.1. Motion Preservation
6.3.2.2. Spine Stimulators
6.3.2.3. Vertebral Compression Fracture (VCF) Devices
6.4. Market Attractiveness Analysis, by Product
7. Global Spine Surgery Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Vertebral Fracture Repair
7.3.2. Spinal Fusion
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Spine Surgery Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Spine Surgery Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Spine Surgery Products Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Fusion Products
10.3.1.1. Cervical Fusion
10.3.1.2. Interbody Fusion
10.3.1.3. Spinal Fixation
10.3.1.4. Minimally Invasive Surgical (MIS) Devices
10.3.1.5. Spine Biologics
10.3.1.5.1. Demineralized Bone Matrix
10.3.1.5.2. Synthetic Bone Graft Substitutes
10.3.2. Non-fusion Products
10.3.2.1. Motion Preservation
10.3.2.2. Spine Stimulators
10.3.2.3. Vertebral Compression Fracture (VCF) Devices
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Vertebral Fracture Repair
10.4.2. Spinal Fusion
10.4.3. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Spine Surgery Products Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Fusion Products
11.3.1.1. Cervical Fusion
11.3.1.2. Interbody Fusion
11.3.1.3. Spinal Fixation
11.3.1.4. Minimally Invasive Surgical (MIS) Devices
11.3.1.5. Spine Biologics
11.3.1.5.1. Demineralized Bone Matrix
11.3.1.5.2. Synthetic Bone Graft Substitutes
11.3.2. Non-fusion Products
11.3.2.1. Motion Preservation
11.3.2.2. Spine Stimulators
11.3.2.3. Vertebral Compression Fracture (VCF) Devices
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Vertebral Fracture Repair
11.4.2. Spinal Fusion
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Spine Surgery Products Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Fusion Products
12.3.1.1. Cervical Fusion
12.3.1.2. Interbody Fusion
12.3.1.3. Spinal Fixation
12.3.1.4. Minimally Invasive Surgical (MIS) Devices
12.3.1.5. Spine Biologics
12.3.1.5.1. Demineralized Bone Matrix
12.3.1.5.2. Synthetic Bone Graft Substitutes
12.3.2. Non-fusion Products
12.3.2.1. Motion Preservation
12.3.2.2. Spine Stimulators
12.3.2.3. Vertebral Compression Fracture (VCF) Devices
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Vertebral Fracture Repair
12.4.2. Spinal Fusion
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Spine Surgery Products Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Fusion Products
13.3.1.1. Cervical Fusion
13.3.1.2. Interbody Fusion
13.3.1.3. Spinal Fixation
13.3.1.4. Minimally Invasive Surgical (MIS) Devices
13.3.1.5. Spine Biologics
13.3.1.5.1. Demineralized Bone Matrix
13.3.1.5.2. Synthetic Bone Graft Substitutes
13.3.2. Non-fusion Products
13.3.2.1. Motion Preservation
13.3.2.2. Spine Stimulators
13.3.2.3. Vertebral Compression Fracture (VCF) Devices
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Vertebral Fracture Repair
13.4.2. Spinal Fusion
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Spine Surgery Products Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Fusion Products
14.3.1.1. Cervical Fusion
14.3.1.2. Interbody Fusion
14.3.1.3. Spinal Fixation
14.3.1.4. Minimally Invasive Surgical (MIS) Devices
14.3.1.5. Spine Biologics
14.3.1.5.1. Demineralized Bone Matrix
14.3.1.5.2. Synthetic Bone Graft Substitutes
14.3.2. Non-fusion Products
14.3.2.1. Motion Preservation
14.3.2.2. Spine Stimulators
14.3.2.3. Vertebral Compression Fracture (VCF) Devices
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Vertebral Fracture Repair
14.4.2. Spinal Fusion
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. DePuy Synthes
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Stryker
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Zimmer Biomet
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Globus Medical
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. K2M
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. NuVasive
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Aesculap Implant Systems, LLC (B. Braun Company)
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. RTI Surgical, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Alphatec Holdings, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Orthofix International N.V.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
